Literature DB >> 25336132

[Comparison of calculated LDL cholesterol (LDL-C) versus measured LDL cholesterol (LDL-M) and potential impact in terms of therapeutic management].

Arnaud Reignier1, Emilie Sacchetto1, Jean-Benoît Hardouin2, Jean-Luc Orsonneau1, Didier Le Carrer1, Odile Delaroche1, Edith Bigot-Corbel1.   

Abstract

LDL-cholesterol value is one of the criteria used by the Haute autorité de santé (HAS) in the management of patients in primary and secondary prevention with the aim to reduce cardiovascular mortality. In this respect, the recommendations have been established based on target to achieve LDL-cholesterol. Currently in France, the determination of LDL-cholesterol is mainly carried out by the Friedewald formula whose limits are well known. However, reliable methods for the determination of LDL-cholesterol exist. We compared the results of calculated and measured LDL-cholesterol obtained from 444 patients presenting normal triglyceridemia values in terms of ranking relative to the thresholds of the HAS. The correlation between the two methods is quite good, but a significant difference (p <0.0001) was observed between the calculated and measured values of LDL-cholesterol. On the other hand in 17% of cases the classification of subjects will be different, with a majority so overestimation of calculated LDL-cholesterol with respect to measured LDL-cholesterol. This overestimation is not proportional, in fact most values measured LDL-cholesterol, the higher the calculate-measured difference is important. The rating difference is particularly important when subjects have between 1 and 3 factors of cardiovascular risk where the target LDL-cholesterol to achieve is between 1.3 and 1.9 g/L. The management of patients with lipid lowering may potentially be dependent on the method used for the determination of LDL-cholesterol.

Entities:  

Keywords:  Friedewald formula; HAS recommendations; calculated LDL-cholesterol; measured LDL-cholesterol

Mesh:

Substances:

Year:  2014        PMID: 25336132     DOI: 10.1684/abc.2014.0990

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  3 in total

1.  Epidemiology of arterial hypertension in Tunisia: Hammam Sousse Sahloul Heart Study (HSHS).

Authors:  Aicha Hamoudi; Asma Ben Abdelaziz; Sarra Melki; Donia Ben Hassine; Nabila Ben Rejeb; Asma Omezzine; Ali Bouslama; Ahmed Ben Abdelaziz
Journal:  Tunis Med       Date:  2022 fevrier

2.  Epidemiology of dyslipidemia in Tunisia, HSHS 3 study (Hammam Sousse Sahloul Heart Study).

Authors:  Zeynab Ben Hdia; Asma Ben Abdelaziz; Sarra Melki; Donia Ben Hassine; Nabila Ben Rejeb; Asma Omezzine; Ali Bouslama; Ahmed Ben Abdelaziz
Journal:  Tunis Med       Date:  2022 avril

Review 3.  Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases.

Authors:  Catherine Coremans; Cédric Delporte; Frédéric Cotton; Phillipe Van De Borne; Karim Zouaoui Boudjeltia; Pierre Van Antwerpen
Journal:  Molecules       Date:  2021-08-30       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.